Santos, Benedito Matheus dos 
; Dias, Bárbara Karina de Menezes; Nakabashi, Myna; Garcia, Célia Regina da Silva
Fonte: Frontiers in Microbiology. Unidades: FCF, ICB
Assuntos: ANTIMALÁRICOS, PLASMODIUM FALCIPARUM, POTÁSSIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Benedito Matheus dos et al. The knockout for G protein-coupled receptor-like PfSR25 increases the susceptibility of malaria parasites to the antimalarials lumefantrine and piperaquine but not to medicine for malaria venture compounds. Frontiers in Microbiology, v. 12, p. 1-12 art. 638869, 2021Tradução . . Disponível em: https://doi.org/10.3389/fmicb.2021.638869. Acesso em: 12 out. 2024.APA
Santos, B. M. dos, Dias, B. K. de M., Nakabashi, M., & Garcia, C. R. da S. (2021). The knockout for G protein-coupled receptor-like PfSR25 increases the susceptibility of malaria parasites to the antimalarials lumefantrine and piperaquine but not to medicine for malaria venture compounds. Frontiers in Microbiology, 12, 1-12 art. 638869. doi:10.3389/fmicb.2021.638869NLM
Santos BM dos, Dias BK de M, Nakabashi M, Garcia CR da S. The knockout for G protein-coupled receptor-like PfSR25 increases the susceptibility of malaria parasites to the antimalarials lumefantrine and piperaquine but not to medicine for malaria venture compounds [Internet]. Frontiers in Microbiology. 2021 ; 12 1-12 art. 638869.[citado 2024 out. 12 ] Available from: https://doi.org/10.3389/fmicb.2021.638869Vancouver
Santos BM dos, Dias BK de M, Nakabashi M, Garcia CR da S. The knockout for G protein-coupled receptor-like PfSR25 increases the susceptibility of malaria parasites to the antimalarials lumefantrine and piperaquine but not to medicine for malaria venture compounds [Internet]. Frontiers in Microbiology. 2021 ; 12 1-12 art. 638869.[citado 2024 out. 12 ] Available from: https://doi.org/10.3389/fmicb.2021.638869
